Background illustration for clinical trials search

Paid Clinical Trials Baltimore

Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

for
Azoospermia
Location: Rockville MD, Edmonton
Sponsor: Paul Shin

Sex: Male

Age: 18+

Code: NCT06941922

Recruiting

Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT04704505

Phase 2, Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

for
Autosomal Dominant Polycystic Kidney Disease
Location: Baltimore MD, Jacksonville FL, Orlando FL, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07228364

Phase 1, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Glen Burnie MD, New York NY, Durham NC, Chapel Hill NC,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase 2, Recruiting

The Mechanistic Biology of Primary Immunodeficiency Disorders

for
Primary Immunodeficiency Disorders
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 0 - 70+

Code: NCT03394053

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Baltimore MD, Brandywine MD, Fairfax VA, Newark DE,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

for
Eosinophilia, Hypereosinophilic Syndrome
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 70+

Code: NCT00091871

Recruiting

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

for
Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05361811

Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Gaithersburg MD, Marlton NJ, North Canton OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06951711

Phase 3, Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for
Weight Management
Location: White Marsh MD, Potomac MD, Newport PA, Midlothian VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07667803

Phase 3, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Baltimore MD, Cleveland OH, Providence RI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase 1, Phase 2, Recruiting

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

for
Progressive Multifocal Leukoencephalopathy
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 2 - 70+

Code: NCT01730131

Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase 1, Phase 2, Recruiting

Ankle Robotics After Stroke

for
Foot Drop, Stroke, Hemiparesis
Location: Baltimore MD
Sponsor: NextStep Robotics Inc.

Sex: All

Age: 18+

Code: NCT04594837

Recruiting

C-Brace Prospective Registry

for
Pareses, Lower Extremity
Location: Linthicum MD, Frederick MD, York PA, Exton PA,
Sponsor: Otto Bock Healthcare Products GmbH

Sex: All

Age: 0+

Code: NCT04640584

Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

for
Prurigo Nodularis
Location: Glendale MD, Rockville MD, Vienna VA, Philadelphia PA,
Sponsor: Galderma R&D

Sex: All

Age: 18+

Code: NCT06988618

Recruiting

Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)

for
Immunosuppression, Periodontal Disease, Healthy Subjects,
Location: Bethesda MD
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)

Sex: All

Age: 7 - 70+

Code: NCT01568697

Recruiting

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: Baltimore MD, Richmond VA, New York NY, Youngstown OH,
Sponsor: NGM Biopharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07033026

Phase 2, Recruiting

Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors

for
Healthy Volunteer
Location: Bethesda MD
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 21 - 60

Code: NCT06819189

Phase 1, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Chevy Chase MD, Philadelphia PA, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting